title: Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: is it safe?
abstract: OBJECTIVE
  Somatostatin and its analogs have recently been introduced in the treatment of chylous effusions in infants and children following surgery. The safety profile of this treatment in critically ill patients has not been fully evaluated.
  
  
  METHODS
  Retrospective case review.
  
  
  METHODS
  Tertiary pediatric cardiac center.
  
  
  METHODS
  A male infant born by cesarean section with a birth weight of 2.6 kg.
  
  
  METHODS
  None.
  
  
  CONCLUSIONS
  We report the association of postoperative chylothorax treated with somatostatin analog (octreotide) and necrotizing enterocolitis in an infant following aortic coarctation repair.
authors.affiliation: Paediatric Intensive Care Unit, Royal Brompton & Harefield NHS Trust, Royal Brompton Hospital, London, UK.
authors.forename: Hadi
authors.initials: H
authors.lastname: Mohseni-Bod
authors.forename: Duncan
authors.initials: D
authors.lastname: Macrae
authors.forename: Zdenek
authors.initials: Z
authors.lastname: Slavik
mesh_terms: D001017:Aortic Coarctation / Q000601:surgery; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D002916:Chylothorax / Q000188:drug therapy* / Q000209:etiology; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy*
chemical_list: D005765:Gastrointestinal Agents; D015282:Octreotide